In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...

A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...

Aerobic exercise may promote myelin repair in some parts of the brain in people with multiple sclerosis (MS), according to a ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition.

The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable ...

Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial in patients suggested nerve damage can be repaired. The treatment involves ...

Decarlos Brown Jr. had harbored paranoid delusions for years, yet under state law he was not considered dangerous enough to ...

A major UK study has revealed that the early warning signs of multiple sclerosis (MS)—including pain, mood changes, and ...